These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 36316)
1. Some biochemical characteristics of hormone-secreting pituitary tumors and of the host's anterior pituitary gland. Nagy I; Macleod RM Mol Cell Endocrinol; 1979 Mar; 13(3):317-32. PubMed ID: 36316 [TBL] [Abstract][Full Text] [Related]
2. Hyperprolactinaemia and DNA synthesis in the pituitary gland of the rat. Burdman JA; Calabrese MT; MacLeod RM J Endocrinol; 1983 Apr; 97(1):65-74. PubMed ID: 6132955 [TBL] [Abstract][Full Text] [Related]
3. Effect of antiestrogens on pituitary prolactin production in normal and pituitary tumor-bearing rats. Nagy I; Valdenegro CA; MacLeod RM Neuroendocrinology; 1980 Jun; 30(6):389-95. PubMed ID: 7383277 [TBL] [Abstract][Full Text] [Related]
5. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine. Canonico PL; Valdenegro CA; MacLeod RM Endocrinology; 1983 Jul; 113(1):7-14. PubMed ID: 6861715 [TBL] [Abstract][Full Text] [Related]
6. Gonadotropin secretion in rats bearing a prolactin-secreting pituitary tumor: effects of naloxone administration. Lamberts SW; Zuiderwijk JM; Bons EG; Uitterlinden P; de Jong FH Fertil Steril; 1981 May; 35(5):557-62. PubMed ID: 6785115 [TBL] [Abstract][Full Text] [Related]
7. Modulation of dopamine receptors by cations in 7315a, MtTW15 and estradiol-induced pituitary tumors. Coenen K; Di Paolo T Biochem Pharmacol; 1990 Sep; 40(6):1373-80. PubMed ID: 2403391 [TBL] [Abstract][Full Text] [Related]
8. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors. Seo H; Refetoff S; Fang VS Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of growth of a prolactin-secreting pituitary tumor in rats by analogs of luteinizing hormone-releasing hormone and somatostatin. de Quijada MG; Redding TW; Coy DH; Torres-Aleman I; Schally AV Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3485-8. PubMed ID: 6134284 [TBL] [Abstract][Full Text] [Related]
10. Prolactin release from MtTW15 and 7315a pituitary tumors is refractory to TRH and VIP stimulation. Judd AM; Canonico PL; MacLeod RM Mol Cell Endocrinol; 1984 Jul; 36(3):221-8. PubMed ID: 6088325 [TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of action of the inhibitory effect of the somatostatin analog SMS 201-995 on the growth of the prolactin/adrenocorticotropin-secreting pituitary tumor 7315a. Lamberts SW; Reubi JC; Uiterlinden P; Zuiderwijk J; van den Werff P; van Hal P Endocrinology; 1986 Jun; 118(6):2188-94. PubMed ID: 2870915 [TBL] [Abstract][Full Text] [Related]
12. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats. Winneker RC; Parsons JA Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344 [TBL] [Abstract][Full Text] [Related]
13. Restoration of pituitary prolactin synthesis and release by the administration of morphine to rats bearing a transplanted prolactin-secreting tumor. Login IS; Nagy I; MacLeod RM Neuroendocrinology; 1981 Aug; 33(2):101-4. PubMed ID: 7266770 [TBL] [Abstract][Full Text] [Related]
14. Regulation and molecular characterization of dopamine D2 receptors in a prolactin-secreting 7315a anterior pituitary tumor. Lew JY; Zawadzka H; Feigenblum D; Tang D; Filer D; Benedetto P; Goldstein M Eur J Pharmacol; 1990 Jun; 188(6):329-34. PubMed ID: 1695574 [TBL] [Abstract][Full Text] [Related]
15. The 7315a pituitary tumor is refractory to dopaminergic inhibition of prolactin release but contains dopamine receptors. Cronin MJ; Valdenegro CA; Perkins SN; MacLeod RM Endocrinology; 1981 Dec; 109(6):2160-6. PubMed ID: 7308146 [No Abstract] [Full Text] [Related]
16. Modulation of dopamine receptor agonist binding sites by cations and estradiol in intact pituitary and 7315a tumors. Abolfathi Z; Di Paolo T Biochem Pharmacol; 1991 Nov; 42(11):2163-9. PubMed ID: 1958234 [TBL] [Abstract][Full Text] [Related]
17. Effects of a luteinizing hormone-releasing hormone analog and tamoxifen on the growth of an estrogen-induced prolactin-secreting rat pituitary tumor and its influence on pituitary gonadotropins. Lamberts SW; Uitterlinden P; Zuiderwijk-Roest JM; Bons-van Evelingen EG; de Jong FH Endocrinology; 1981 May; 108(5):1878-84. PubMed ID: 6452261 [No Abstract] [Full Text] [Related]
18. Prolactin-secreting pituitary adenomas in women. IV. Pituitary function in amenorrhea associated with normal or abnormal serum prolactin and sellar polytomography. Chang RJ; Keye WR; Monroe SE; Jaffe RB J Clin Endocrinol Metab; 1980 Oct; 51(4):830-5. PubMed ID: 6774995 [No Abstract] [Full Text] [Related]
19. Effects of gonadotropin-releasing hormone and its agonists on prolactin secretion from normal and tumorous pituitary cells. Lamberts SW; Uitterlinden P; Reubi JC; de Jong FH Neuroendocrinology; 1989 Feb; 49(2):157-63. PubMed ID: 2524674 [TBL] [Abstract][Full Text] [Related]
20. Tissue culture studies on human pituitary tumours: long term release of anterior pituitary hormones into the culture medium. Lipson LG; Beitins IZ; Kornblith PL; McArthur JW; Friesen HG; Kliman B; Kjellberg RN Acta Endocrinol (Copenh); 1979 Mar; 90(3):421-33. PubMed ID: 218413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]